|
Published by: Mintel International Group Ltd.
Published: Nov. 1, 2006 - 92 Pages
Table of Contents
- SCOPE AND THEMES
- What you need to know
- Definition
- Abbreviations and terms
- Abbreviations
- Terms
- EXECUTIVE SUMMARY
- Snapshot of the market
- Demographic changes help drive market
- Increased work stress
- Consumer ads for prescription drugs soar
- Lack of health insurance and cross-channel competition hold back market
- Sanofi-Aventis (Ambien’s) dominance begins to wane
- Massive growth in direct-to-consumer adspend from 2004-05
- Retail activity
- Incidence of sleep issues and severity
- Use of prescription and OTC medications for sleep issues
- Remedies for sleeplessness
- Reasons for sleep disturbance
- Choice of prescription or OTC sleep aids
- Sales strong for now, but will probably start declining sometime in 2008
- MARKET DRIVERS
- Prevalence of sleep disorders
- Figure 1: Sleep habits, by age, September 2006
- Baby Boomers have higher use of sleep aids
- Figure 2: Incidence of use of medication for insomnia/sleep disorders, by age, May 2005-June 2006
- Figure 3: Total US population, by age group, 2001-11
- Females have more sleep issues
- Figure 4: Total US female population, by age group, 2001-11
- Increased work hours lead to increased stress and sleeplessness
- Pronounced spend on direct-to-consumer (DTC) ads
- Lack of access to health insurance
- Even those with access to employer-sponsored plans leaving system
- Competition from night time analgesics
- Figure 5: Total US retail sales of PM analgesics, at current and constant prices, 2000-04
- MARKET SIZE AND TRENDS
- Market size
- Figure 6: Total US retail sales of sleep aids, at current and constant prices, 2001-06
- Figure 7: Graph: Total US retail sales of sleep aids, at current and constant prices, 2001-06
- MARKET SEGMENTATION
- Prescription sales dominate the market
- Figure 8: US sales of sleep aids, by sector, 2004 and 2006
- Prescription sleep aids
- Figure 9: US sales of prescription sleep aids, at current and constant prices, 2001-06
- OTC sleep aid tablets
- Figure 10: US FDM sales of OTC sleep aid tablets, at current and constant prices, 2001-06
- OTC sleep aid liquids
- Figure 11: US FDM sales of OTC sleep aid liquids, at current and constant prices, 2001-06
- SUPPLY STRUCTURE
- COMPANY AND BRAND SALES OF SLEEP AIDS
- Introduction
- Prescription sleep aids
- Figure 12: Manufacturer brand sales of prescription sleep aids in the US, 2004 and 2005
- OTC sleep aids
- Figure 13: Manufacturer FDM brand sales of OTC sleep aids in the US, 2004 and 2006
- COMPANY PROFILES-PRESCRIPTION MANUFACTURERS
- Sanofi-Aventis
- Sepracor Inc
- GlaxoSmithKline plc
- King Pharmaceuticals
- Takeda Pharmaceutical Company Limited
- COMPANY PROFILES-OTC MANUFACTURERS
- GlaxoSmithKline
- Johnson & Johnson/McNeil
- Pfizer
- ADVERTISING AND PROMOTION
- Introduction
- Figure 14: Prescription sleep aids, adspend, by brand, 2004 and 2005
- Ambien (Sanofi-Aventis)
- Overview
- Ambien CR
- Figure 15: Ambien Advertisement, 2006
- Lunesta (Sepracor)
- Overview
- Lunesta
- Figure 16: Lunesta Advertisement, 2006
- Rozerem (Takeda)
- Figure 17: Rozerem advertisement, 2006
- OTC brand ads
- MidNite Herbal Sleep Aid
- Figure 18: MidNite Herbal Advertisement, 2006
- RETAIL DISTRIBUTION
- Introduction
- Figure 19: US FDM sales of OTC sleep aids, by channel, 2004 and 2006
- Drug stores
- Figure 20: US drug store sales of sleep aids, at current and constant prices, 2001-06
- Supermarkets
- Figure 21: US supermarket sales of sleep aids, at current and constant prices, 2001-06
- Mass merchandisers
- Figure 22: US mass merchandiser sales of sleep aids, at current and constant prices, 2001-06
- THE CONSUMER
- Introduction
- Summary
- Incidence of sleep issues and severity
- Use of prescription and OTC medications for sleep issues
- Remedies for sleeplessness
- Reasons for sleep disturbance
- Choice of prescription or OTC sleep aids
- Incidence of anxiety or insomnia/sleep disorder
- Figure 23: Incidence of anxiety or insomnia/sleep disorder, May 2005-June 2006
- Figure 24: Incidence of anxiety or insomnia/sleep disorder, by gender, May 2005-June 2006
- Figure 25: Incidence of anxiety or insomnia/sleep disorder, by race/ethnicity, May 2005-June 2006
- Sleep habits
- Figure 26: Sleep habits, September 2006
- Figure 27: Sleep habits, by gender, September 2006
- Figure 28: Sleep habits, by age, September 2006
- Figure 29: Sleep habits, by employment status, September 2006
- Severity of insomnia/sleep disorder
- Figure 30: Severity of insomnia/sleep disorder, May 2005-June 2006
- Figure 31: Severity of insomnia/sleep disorder, by level of education attained, May 2005-June 2006
- Use of medication to treat anxiety or insomnia/sleep disorder
- Figure 32: Incidence of use of medication for insomnia/sleep disorders, May 2005-June 2006
- Figure 33: Incidence of use of medication for insomnia/sleep disorders, by gender, May 2005-June 2006
- Figure 34: Incidence of use of medication for insomnia/sleep disorders, by age, May 2005-June 2006
- Figure 35: Incidence of use of medication for insomnia/sleep disorders, by level of education attained, May 2005- June 2006
- Use of Ambien or Sonata
- Figure 36: Use of Ambien or Sonata-all prescription drug users, May 2005-June 2006
- Figure 37: Use of Ambien or Sonata-respondents with insomnia/sleep disorder, May 2005-June 2006
- Figure 38: Use of Ambien or Sonata-respondents with insomnia/sleep disorder, by gender, May 2005-June 2006
- Figure 39: Use of Ambien or Sonata-respondents with insomnia/sleep disorder, by level of education attained, May 2005-June 2006
- Remedies for insomnia
- Figure 40: Remedies for insomnia, September 2006
- Figure 41: Remedies for insomnia, by gender, September 2006
- Figure 42: Remedies for insomnia, by age, September 2006
- Figure 43: Remedies for insomnia, by education level attained, September 2006
- Figure 44: Remedies for insomnia, by employment status, September 2006
- Activities/room aids used to aid sleep
- Figure 45: Activities/room aids used to aid sleep, September 2006
- Figure 46: Activities/room aids used to aid sleep, by gender, September 2006
- Figure 47: Activities/room aids used to aid sleep, by marital status, September 2006
- Figure 48: Activities/room aids used to aid sleep, by age, September 2006
- Figure 49: Activities/room aids used to aid sleep, by household income, September 2006
- Figure 50: Activities/room aids used to aid sleep, by presence of children under age 18 in household, September 2006
- Figure 51: Activities/room aids used to aid sleep, by employment status, September 2006
- Reasons for sleep disturbance
- Figure 52: Reasons for sleep disturbance, September 2006
- Figure 53: Reasons for sleep disturbance, by gender, September 2006
- Figure 54: Reasons for sleep disturbance, by age, September 2006
- Figure 55: Reasons for sleep disturbance, by Hispanic origin, September 2006
- Figure 56: Reasons for sleep disturbance, by presence and number of children under age 18 in household, September 2006
- Figure 57: Reasons for sleep disturbance, by level of education attained, September 2006
- Concerns/opinions regarding sleep aids
- Figure 58: Concerns/opinions regarding sleep aids, September 2006
- Figure 59: Concerns/opinions regarding sleep aids, by age, September 2006
- Figure 60: Concerns/opinions regarding sleep aids, by employment status, September 2006
- Figure 61: Concerns/opinions regarding sleep aids, by Hispanic status, September 2006
- Side effects of sleep aids
- Figure 62: Side effects of sleep aids, September 2006
- Figure 63: Side effects of sleep aids, by age, September 2006
- Figure 64: Side effects of sleep aids, by number of people in household, September 2006
- Reasons for choosing OTC over prescription sleep aids
- Figure 65: Reasons for choosing OTC over prescription sleep aids, September 2006
- Figure 66: Reasons for choosing OTC over prescription sleep aids, by household income, September 2006
- Reasons for choosing prescription sleep aids over OTC
- Figure 67: Reasons for choosing prescription sleep aids over OTC, September 2006
- Figure 68: Reasons for choosing prescription sleep aids over OTC, by gender, September 2006
- Figure 69: Reasons for choosing prescription sleep aids over OTC, by employment status, September 2006
- FUTURE AND FORECAST
- FUTURE TRENDS
- Aging population drives overall prescription sales
- Concerns for safety could slow sales of prescription sleep aids
- Loss of patent protection for Ambien will negatively affect market-at some point soon
- Competition from natural sleep aids such as melatonin and Valerian
- MARKET FORECAST
- Sleep aids
- Figure 70: Forecast of total US sales of sleep aids, at current and constant prices, 2006-08
- Prescription sleep aids
- Figure 71: Forecast of US sales of prescription sleep aids, at current and constant prices, 2006-08
- OTC sleep aids
- Figure 72: Forecast of US FDM sales of OTC sleep aids, at current and constant prices, 2006-08
- Forecast factors
- APPENDIX: TRADE ASSOCIATIONS
- APPENDIX: NEW PRODUCT BRIEFS
- Walgreens: Extra Strength Acetaminophen PM
- Lil’ Drug Store Products: Legatrin PM
- CVS: Nighttime Sleep-Aid
AbstractEncompassing both the prescription and over-the-counter (OTC) sleep aids segments, this report analyzes data from Mintel’s exclusive consumer research, the Spring 2006 Simmons NCS and sales data from IRI. In addition to defining the demographic groups most likely to use sleep aids, Mintel’s research reveals reasons for not using sleep aids, which can help suppliers and marketers address consumer concerns about sleep aids.
The sleep aids market is in a period of strong expansion, particularly in the prescription segment, though new brand introductions and loss of patent protection for Ambien in 2006 will begin to change the major players within the segment. Examined within the report are brand and manufacturer sales for both the prescription and OTC market segments, and the marketing methods used by category leaders.
The most significant impediment to expanding the sleep aids market is the fear of addiction and side effects. Mintel’s exclusive research explores the degree of concern regarding side effects of OTC and prescription sleep aids, and concerns for addiction regarding these products among demographic groups. Approximately 150 million Americans experience at least occasional difficulty falling asleep or staying asleep. Therefore, there is significant room for expansion if new products can be developed to entice those who fear addiction/side-effects. New marketing strategies could also lure those who have previously tried sleep aids, but who had negative side effects.
This report covers any OTC or prescription remedy marketed specifically for sleep such as Nytol, Sominex, or Ambien. Excluded are products not specifically for sleep assistance such as cold medicines. Also excluded are accessories designed to assist with sleep such as Breathe Right nasal strips, Breathe Right throat spray, black-out masks, ear plugs, or electronic sound machines. Herbal or hormonal products such as melatonin or valerian root are also excluded.
This report contains US IRI InfoScan data.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
